ResidualPlaybeta Open the radar

Infectonator 3: Apocalypse

Toge Productions · 2018 · $12.99 · Indie · deal grade B

Measured on 2026-10-05 07:50 UTC. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

  • Estimated net residual revenue: $710 to $1.1k per month
  • Opportunity: $1.4k per month at x1.60 dormancy
  • Estimated lifetime owners: 62.8k
  • 83% positive across 1381 reviews · 12.7 reviews/month

Why it's flagged

  • Developer silent for 6.8 years
  • Studio active elsewhere (4 titles tracked), so this one may welcome a partner
  • Last discounted 0 months ago, 9 sales in the last 12 months
  • Proven demand elasticity: x1.5 review velocity during past deep sales

Analyst notes (AI-assisted)

Note written 2026-08-25; the live figures above take precedence over any numbers in it.

Infectonator 3: Apocalypse is a roguelike indie strategy game from 2018 where players manage and mutate undead hordes.

This title sits in an awkward design crossroads: the franchise shift to roguelike mechanics alienated core players who valued the series' prior progression systems, yet the game maintains solid engagement metrics and a mid-sized owner base. Revival opportunity exists if a new publisher revisits the design intent (straight campaign vs. roguelike loop), or acquisition makes sense for a studio building a catalog of indie strategy IP with established communities. Most realistic play: publishing.

  • Risk: Core series fans actively dislike the roguelike pivot; returning to a campaign-driven design would require substantial creative rework and risk further alienation.
  • Risk: Developer has posted no public updates in nearly 80 months; unclear if studio retains bandwidth or interest for post-launch support.
  • Risk: Median play session is under 8 hours; high elasticity (1.58) suggests price sensitivity may limit residual upside without fresh content or design hooks.

This case as Markdown · Estimates carry ±30-50% error per title.